176 related articles for article (PubMed ID: 12914820)
21. The complement system in human reproduction.
Vanderpuye OA; Labarrere CA; McIntyre JA
Am J Reprod Immunol; 1992; 27(3-4):145-55. PubMed ID: 1384536
[TBL] [Abstract][Full Text] [Related]
22. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases.
Miwa T; Song WC
Int Immunopharmacol; 2001 Mar; 1(3):445-59. PubMed ID: 11367529
[TBL] [Abstract][Full Text] [Related]
23. [Complement regulatory factors and immunologic recognition mechanism between species].
Seya T; Matsunoto M
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
[No Abstract] [Full Text] [Related]
24. The complement receptors CD46, CD55 and CD59 are regulated by the tumour microenvironment of head and neck cancer to facilitate escape of complement attack.
Kesselring R; Thiel A; Pries R; Fichtner-Feigl S; Brunner S; Seidel P; Bruchhage KL; Wollenberg B
Eur J Cancer; 2014 Aug; 50(12):2152-61. PubMed ID: 24915776
[TBL] [Abstract][Full Text] [Related]
25. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9 generated human CD46, CD55 and CD59 knockout cell lines as a tool for complement research.
Thielen AJF; van Baarsen IM; Jongsma ML; Zeerleder S; Spaapen RM; Wouters D
J Immunol Methods; 2018 May; 456():15-22. PubMed ID: 29447841
[TBL] [Abstract][Full Text] [Related]
27. Anti-inflammatory and immunosuppressive effects of recombinant soluble complement receptors.
Fearon DT
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):43-6. PubMed ID: 1718643
[TBL] [Abstract][Full Text] [Related]
28. Relative roles of hCD46 and hCD55 in the regulation of hyperacute rejection.
Verbakel CA; Bonthuis F; Eerhart SE; van Dixhoorn M; Grosveld F; Marquet RL; IJzermans JN
Transplant Proc; 2000 Aug; 32(5):903-4. PubMed ID: 10936266
[No Abstract] [Full Text] [Related]
29. Membrane-bound complement regulatory proteins inhibit complement activation by an immunotherapeutic mAb in a syngeneic rat colorectal cancer model.
Gelderman KA; Hakulinen J; Hagenaars M; Kuppen PJ; Meri S; Gorter A
Mol Immunol; 2003 Sep; 40(1):13-23. PubMed ID: 12909127
[TBL] [Abstract][Full Text] [Related]
30. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
31. [Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation].
Heckl-Ostreicher B; Kirschfink M
Immun Infekt; 1995 Apr; 23(2):53-4. PubMed ID: 7538095
[TBL] [Abstract][Full Text] [Related]
32. Expression of complement regulating proteins on FDC.
Schgmitz J; Petrasch S; Mews I; van Lunzen J; Kluxen B; Würzner R; Schmitz H; Racz P
Adv Exp Med Biol; 1995; 378():293-5. PubMed ID: 8526076
[No Abstract] [Full Text] [Related]
33. Decay-accelerating factor and membrane cofactor protein.
Lublin DM; Atkinson JP
Curr Top Microbiol Immunol; 1990; 153():123-45. PubMed ID: 1688754
[No Abstract] [Full Text] [Related]
34. Functional domains, structural variations and pathogen interactions of MCP, DAF and CR1.
Hourcade D; Liszewski MK; Krych-Goldberg M; Atkinson JP
Immunopharmacology; 2000 Aug; 49(1-2):103-16. PubMed ID: 10904110
[TBL] [Abstract][Full Text] [Related]
35. Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.
Gasque P; Thomas A; Fontaine M; Morgan BP
J Neuroimmunol; 1996 May; 66(1-2):29-40. PubMed ID: 8964911
[TBL] [Abstract][Full Text] [Related]
36. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
37. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
Taylor CT; Johnson PM
Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
[TBL] [Abstract][Full Text] [Related]
38. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
Brodbeck WG; Mold C; Atkinson JP; Medof ME
J Immunol; 2000 Oct; 165(7):3999-4006. PubMed ID: 11034410
[TBL] [Abstract][Full Text] [Related]
39. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
40. Protection of xenogeneic cells from human complement-mediated lysis by the expression of human DAF, CD59 and MCP.
Huang J; Gou D; Zhen C; Jiang D; Mao X; Li W; Chen S; Cai C
FEMS Immunol Med Microbiol; 2001 Oct; 31(3):203-9. PubMed ID: 11720816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
